Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aditxt Inc.

ADTX
Current price
2.35 USD -0.13 USD (-5.24%)
Last closed 2.41 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 012 282 USD
Yield for 12 month +132.67 %
1Y
3Y
5Y
10Y
15Y
ADTX
21.11.2021 - 28.11.2021

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. It is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

61 USD

P/E ratio

Dividend Yield

Current Year

+749 475 USD

Last Year

+933 715 USD

Current Quarter

+124 486 USD

Last Quarter

+220 978 USD

Current Year

+108 340 USD

Last Year

+166 936 USD

Current Quarter

+17 564 USD

Last Quarter

+35 240 USD

Key Figures ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 305 946 USD
Operating Margin TTM -6502.91 %
PE Ratio
Return On Assets TTM -117.53 %
PEG Ratio
Return On Equity TTM -698.6 %
Wall Street Target Price 61 USD
Revenue TTM 749 475 USD
Book Value -11.48 USD
Revenue Per Share TTM 5.19 USD
Dividend Share
Quarterly Revenue Growth YOY -61.5 %
Dividend Yield
Gross Profit TTM 166 936 USD
Earnings Share -12 USD
Diluted Eps TTM -12 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 18.08.2023
Dividend Date

Stock Valuation ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.3707
Enterprise Value Revenue 12.8974
Price Sales TTM 6.6877
Enterprise Value EBITDA -0.376
Price Book MRQ 0.3003

Financials ADTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADTX

For 52 weeks

2.6 USD 76.4 USD
50 Day MA 3.48 USD
Shares Short Prior Month 35 050
200 Day MA 9.19 USD
Short Ratio 0.18
Shares Short 19 477
Short Percent 1.17 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics